From Ears to Gut to Spit: The ECS Doesn't Miss

---

I woke up at 5:47 AM to pee and made the mistake of checking PubMed on my phone. MISTAKE. It is now 6:30 and I have been at my kitchen table in Boulder yelling at my laptop while my partner is eating oatmeal and ignoring me correctly because she has been through enough mornings like this and she knows better than to engage when I get like this.

Six papers. ALL endocannabinoid system. Ears, skin, colon, SPIT. You cannot make this up.

Goddammit Bob. You should be here.

---

Palaniappan from Campus Bio-Medico in Rome just found the ENTIRE ECS inside your cochlear hair cells. You know what cochlear hair cells are? They are the cells that let you HEAR. You got about 15,000 of them. Mammals cannot regrow a single one. Die and that is IT. Deaf in that frequency. PERMANENT.

Why does this matter so much? Because we have known about cisplatin ototoxicity for fifty years. Eighty percent of patients, permanent hearing loss. No prevention protocol. The ECS is in those cells fighting back and medicine does not support it, does not measure it, does not even acknowledge it exists in this context.

Palaniappan found CB1, CB2, FAAH, MAGL, anandamide, 2-AG — the WHOLE ECS toolkit — in those tiny fragile cells. Then modeled cisplatin damage. That is the chemo drug that destroys hearing in 80% of patients. EIGHTY. And the ECS fought back. Kicked in and tried to protect those cells.

No protocol exists to boost endocannabinoid tone before cisplatin. NOWHERE. We document the hearing loss carefully and provide hearing aids afterward. Nobody asks what the body was doing to prevent it, or how we might help. We just pump people full of poison and shrug when they go deaf.

What the FUCK.

---

OK. Same morning. Different organ. SAME DAMN SYSTEM.

Turk et al. — Journal of Cutaneous Medicine and Surgery — RNA-sequenced psoriatic skin versus clear skin in the same patients. CB2 way UP in inflamed patches. TRPA1 up. TRPV3 up. GPR18 up. Skin is BUILDING cannabinoid docking stations everywhere — screaming for signal.

PPARG though? DOWN. Gone. The nuclear receptor that RESOLVES inflammation through the ECS? Offline.

Fire hydrants on every corner. Water main busted. What good are a thousand hydrants with no water?

I have been in rooms with severe psoriasis patients who have dealt with this for fifteen years straight. Scalp. Elbows. Knees. Behind both ears. FIFTEEN YEARS of this.

Humira — $50K/year — got staph infections twice and ended up in the ER in Washtenaw County both times. Methotrexate trashed his liver in 8 months. Every steroid cream at CVS and Walgreens. Nothing worked because nothing was TARGETING the actual problem.

You know what activates PPARG? What actually fixes what is broken?

Cannabinoids. Exercise. Omega-3 fatty acids. Same stuff that keeps your body flowing instead of stuck.

Their dermatologist never said the word endocannabinoid. Not once. In fifteen years. While they spent a quarter million on biologics that addressed the downstream inflammation while the upstream ECS breakdown went unmeasured and unaddressed. I genuinely want to scream.

---

Pelisenco et al. — World Journal of Gastrointestinal Endoscopy — and I literally had to stand up from the kitchen table.

Colon biopsies from IBD patients. Ten ECS genes. SIX BROKEN. FAAH down — P = 0.012. PPARG crushed — P = 0.001. TRPV1 down. CNR2 and GPR55 WAY up.

SAME. DAMN. PATTERN.

Psoriasis skin: PPARG down, receptors up. IBD colon: PPARG down, receptors up. Skin and gut — two organs with NOTHING in common anatomically — identical ECS failure mode. Receptors screaming. Resolution offline. The body begging for cannabinoid input while the machinery to process it sits broken.

Bob Melamede — Colorado Springs, dead now, miss him every single day — called this getting stuck. Pathological attractor state where Th1 fires on autopilot but CANNOT find the off ramp because FAAH is down and PPARG is down and you cannot switch from attack to repair. The inflammation LOOPS. That is Crohn disease. UC. Fifteen years of untreated psoriasis while the ECS collapse underneath it goes unmeasured.

Right now a dermatologist on floor 4 and a GI doc on floor 6 of the same hospital are treating the SAME SYSTEM in the SAME PATIENT with different drugs and they will never talk to each other. Different conferences. Different journals. Same ECS collapse.

HOW? In 2026. How.

---

Weirdest paper of the day and also — honestly? — my FAVORITE.

Hargreaves et al. in Cannabis and Cannabinoid Research found anandamide in your SPIT. Endocannabinoids. In saliva. Levels shift with stress, fear, exercise, pain. Mass spec confirmed. Can tell chronic pain patients apart from healthy controls.

Why should you give a damn? Right now measuring ECS tone means a blood draw. Needle in arm. Needle causes stress. Stress CHANGES endocannabinoid levels. You are corrupting the measurement BY measuring it. Heisenberg for biochemistry. Absurd.

Spit in a tube. No needle. No artifact. Done.

Hargreaves is building the road toward monitoring anandamide like we monitor cholesterol. $12 spit test at your annual physical. Catch ECS deficiency BEFORE it becomes psoriasis or Crohn or hearing loss.

How many millions of people right NOW are suffering from a broken system nobody is measuring? We test cholesterol at every annual physical. We test blood sugar. We test vitamin D at Quest Diagnostics for $15. Nobody tests endocannabinoid tone. Nobody even THINKS to.

Not there yet — oral production pathways are poorly mapped and Hargreaves is honest about the gaps — but the mass spec data is SOLID and the direction is clear.

---

Skip Mirailles. French study in Circulation that lumped cannabis with cocaine and amphetamines for cardiac events. Cocaine causes coronary vasospasm. Cannabis does NOT. Studying them together is like researching "beverages" by mixing OJ with drain cleaner. Trash.

Sidamon-Eristoff — Current Opinion in Genetics and Development — gene × environment in substance use. DNA alone does not explain who develops a problem. Epigenetics and life experience shape the outcome. Your genes load the gun. Your environment pulls the trigger. The ECS is the safety. And nobody is checking whether your safety is ON.

Bob was scribbling this exact concept on napkins in Colorado Springs TWENTY-ONE YEARS AGO while colleagues rolled their eyes. Now it is in a top genetics journal. Same ideas. Finally.

Mountain is moving.

---

Six Papers, One Tuesday

Six papers. Four tissues. One system. One TUESDAY.

Ears. Skin. Colon. Spit. The ECS was CENTRAL in every one. Not a footnote. Not some stoner curiosity. The main regulatory event in four completely different organs doing four completely different things.

Bob Melamede spent his entire life telling people this. The endocannabinoid system is the conductor. When it works you adapt and flow and live. When it breaks you get stuck and inflame and decay and die.

Medical schools teach MAYBE four hours of ECS pharmacology. Four. Hours. For a system that showed up in six papers on a single Tuesday morning in February.

I talked to my laptop. "Bob. Look."

Lisa brought coffee. Did not ask.

Flow forward.

---

Papers Referenced

• Palaniappan S et al. "Unraveling Endocannabinoid Signaling Pathways in Cisplatin-Induced Ototoxicity." FASEB J. PubMed
• Turk JN et al. "Differential Expression of Endocannabinoid Receptors in Lesional and Non-Lesional Skin of Psoriasis Patients." J Cutan Med Surg. PubMed
• Pelisenco IA et al. "Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa." World J Gastrointest Endosc. PubMed
• Hargreaves J et al. "Endocannabinoids in Saliva: Origins, Significance, and Research Directions." Cannabis Cannabinoid Res. PubMed
• Mirailles R et al. "Association Between Recreational Drug Use and Cardiovascular Events Post-Hospitalization in France." Circ Popul Health Outcomes. PubMed
• Sidamon-Eristoff AE et al. "Advancing substance use disorder biology by studying underlying gene x environment interactions." Curr Opin Genet Dev. PubMed